AIM: An audit of serrated polyps diagnosed over a 4-year period: 2009 to 2012 was undertaken to ascertain the reporting trends of sessile serrated polyps (SSP). METHODS: All right sided hyperplastic polyps (HP) proximal to the splenic flexure and all polyps designated SSP were retrieved from the study period. Three pathologists blinded to the original diagnosis re-examined the slides. Recent American College of Gastroenterology guidelines for the diagnosis of SSP was utilised. RESULTS: No cases of SSP were diagnosed in 2009. In 2010, 32 right-sided cases were encountered, 83 confirmed in 2011 and 134 confirmed in 2012. The vast majority of these were right-sided. With regards to right-sided HP that were re-classified as SSP the data is as follows: 20 of 66 in 2009 (30%); 58 of 91 in 2010 (64%); 42 of 106 (40%) in 2011 and 69 of 206 in 2012 (33%). CONCLUSIONS: This study has demonstrated an almost exponential increase in the diagnosis of SSP over a 4-year period. In addition, 30 to 64% of right-sided HP were re-classified as SSP over the 4-year period suggesting that greater awareness of the diagnostic criteria for SSP is required. SSP is an important precursor lesion in the serrated pathway of colorectal cancer. Its recognition is important for surveillance and therapeutic strategies.
AIM: An audit of serrated polyps diagnosed over a 4-year period: 2009 to 2012 was undertaken to ascertain the reporting trends of sessile serrated polyps (SSP). METHODS: All right sided hyperplastic polyps (HP) proximal to the splenic flexure and all polyps designated SSP were retrieved from the study period. Three pathologists blinded to the original diagnosis re-examined the slides. Recent American College of Gastroenterology guidelines for the diagnosis of SSP was utilised. RESULTS: No cases of SSP were diagnosed in 2009. In 2010, 32 right-sided cases were encountered, 83 confirmed in 2011 and 134 confirmed in 2012. The vast majority of these were right-sided. With regards to right-sided HP that were re-classified as SSP the data is as follows: 20 of 66 in 2009 (30%); 58 of 91 in 2010 (64%); 42 of 106 (40%) in 2011 and 69 of 206 in 2012 (33%). CONCLUSIONS: This study has demonstrated an almost exponential increase in the diagnosis of SSP over a 4-year period. In addition, 30 to 64% of right-sided HP were re-classified as SSP over the 4-year period suggesting that greater awareness of the diagnostic criteria for SSP is required. SSP is an important precursor lesion in the serrated pathway of colorectal cancer. Its recognition is important for surveillance and therapeutic strategies.
Authors: David A Drew; Allen Mo; James J Grady; Richard G Stevens; Joel B Levine; Bruce M Brenner; Joseph C Anderson; Faripour Forouhar; Michael J O'Brien; Thomas J Devers; Daniel W Rosenberg Journal: Mol Cancer Res Date: 2017-12-08 Impact factor: 5.852
Authors: Seth D Crockett; Rebecca A Gourevitch; Michele Morris; David S Carrell; Sherri Rose; Zhuo Shi; Julia B Greer; Robert E Schoen; Ateev Mehrotra Journal: Endoscopy Date: 2018-04-24 Impact factor: 10.093
Authors: Xiaosheng He; Dong Hang; Kana Wu; Jennifer Nayor; David A Drew; Edward L Giovannucci; Shuji Ogino; Andrew T Chan; Mingyang Song Journal: Gastroenterology Date: 2019-07-11 Impact factor: 22.682
Authors: Manish Singla; Jean D Kemp; Michael E Goldberg; Vito V Cirigliano; Gilda M Bobele; Ganesh R Veerappan; Patrick E Young Journal: Turk J Gastroenterol Date: 2021-10 Impact factor: 1.852
Authors: Rebecca A Gourevitch; Sherri Rose; Seth D Crockett; Michele Morris; David S Carrell; Julia B Greer; Reetesh K Pai; Robert E Schoen; Ateev Mehrotra Journal: Am J Gastroenterol Date: 2018-01-30 Impact factor: 10.864
Authors: Helen G Coleman; Maurice B Loughrey; Liam J Murray; Brian T Johnston; Anna T Gavin; Martha J Shrubsole; Shivaram K Bhat; Patrick B Allen; Vivienne McConnell; Marie M Cantwell Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-16 Impact factor: 4.254